Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D)

NCT02697201 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Insulin Resistance

Interventions

DRUG: Intralipid
DRUG: Saline

Sponsor

Pennington Biomedical Research Center